SEI INVESTMENTS CO

Position in ESPR — Esperion Therapeutics, Inc.

CIK 350894 OAKS, PA

Position in ESPR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

+$0 QoQ

Shares Held

64,925

-44.1% QoQ

Ownership

0.025%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SEI INVESTMENTS CO holds $374,044,345 across 37 Drug Manufacturers - Specialty & Generic names. ESPR ranks #37 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	5,284,773	$130,058,261
2	VTRS	Viatris Inc	3,165,469	$50,267,647
3	TEVA	Teva Pharmaceutical Industries Ltd	1,105,005	$37,437,568
4	NBIX	Neurocrine Biosciences Inc	185,545	$31,271,754
5	ZTS	Zoetis Inc.	237,394	$17,059,132
6	KNSA	Kiniksa Pharmaceuticals International, plc	188,565	$12,058,731
7	AMRX	Amneal Pharmaceuticals, Inc.	690,897	$11,959,425
8	LNTH	Lantheus Holdings, Inc.	98,305	$10,905,956

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	—	64,925	-44.1%	Shares	Sole	2026-08-14
2026-03-31	—	116,229	+52.9%	Shares	Sole	2026-05-13
2025-12-31	—	75,992	-2.3%	Shares	Sole	2026-02-13
2025-09-30	—	77,751	+85.7%	Shares	Sole	2025-11-13
2024-12-31	—	41,878	+8.6%	Shares	Sole	2025-02-11
2024-09-30	—	38,556	+182.8%	Shares	Sole	2024-11-12
2023-09-30	—	13,633	-35.0%	Shares	Sole	2023-11-14
2023-06-30	—	20,979	0.0%	Shares	Sole	2023-08-11
2023-03-31	—	20,979	+78.7%	Shares	Sole	2023-05-12
2022-12-31	—	11,737	-7.0%	Shares	Sole	2023-02-10
2022-09-30	—	12,617	-4.8%	Shares	Sole	2022-11-14
2020-12-31	—	13,258	-89.8%	Shares	Sole	2021-02-08
2020-09-30	—	130,006	-6.2%	Shares	Sole	2020-12-04
2020-06-30	—	138,577	+31.4%	Shares	Sole	2020-08-17
2020-03-31	—	105,439	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.